These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37921776)

  • 21. Discovery of 1-(Hetero)aryl-β-carboline Derivatives as IDO1/TDO Dual Inhibitors with Antidepressant Activity.
    Zhang Y; Li Y; Chen X; Chen X; Chen C; Wang L; Dong X; Wang G; Gu R; Li F; Han F; Chen D
    J Med Chem; 2022 Aug; 65(16):11214-11228. PubMed ID: 35938398
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
    J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan 2,3-dioxygenase in tumor cells is associated with resistance to immunotherapy in renal cell carcinoma.
    Sumitomo M; Takahara K; Zennami K; Nagakawa T; Maeda Y; Shiogama K; Yamamoto Y; Muto Y; Nukaya T; Takenaka M; Fukaya K; Ichino M; Sasaki H; Saito K; Shiroki R
    Cancer Sci; 2021 Mar; 112(3):1038-1047. PubMed ID: 33410234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ups, downs and new trends of IDO1 inhibitors.
    Chen S; Tan J; Zhang A
    Bioorg Chem; 2021 May; 110():104815. PubMed ID: 33773223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4,6-Disubstituted-1H-Indazole-4-Amine derivatives with immune-chemotherapy effect and in vivo antitumor activity.
    Huo C; Luo Z; Ning X; Kang X; Yan Q; Guo Y; Li G; Wang Z; Li Y; Qian S
    Eur J Med Chem; 2022 Nov; 241():114625. PubMed ID: 35952399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor.
    Song X; Si Q; Qi R; Liu W; Li M; Guo M; Wei L; Yao Z
    Front Immunol; 2021; 12():800630. PubMed ID: 35003126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors.
    Pan L; Zheng Q; Chen Y; Yang R; Yang Y; Li Z; Meng X
    Eur J Med Chem; 2018 Sep; 157():423-436. PubMed ID: 30103191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells.
    Cecchi M; Paccosi S; Silvano A; Eid AH; Parenti A
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
    Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
    Sari S; Tomek P; Leung E; Reynisson J
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors.
    Schramme F; Crosignani S; Frederix K; Hoffmann D; Pilotte L; Stroobant V; Preillon J; Driessens G; Van den Eynde BJ
    Cancer Immunol Res; 2020 Jan; 8(1):32-45. PubMed ID: 31806638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines.
    Paccosi S; Cecchi M; Silvano A; Fabbri S; Parenti A
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3155-3163. PubMed ID: 32776284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
    Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z
    Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond.
    Muller AJ; Manfredi MG; Zakharia Y; Prendergast GC
    Semin Immunopathol; 2019 Jan; 41(1):41-48. PubMed ID: 30203227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.
    Pilotte L; Larrieu P; Stroobant V; Colau D; Dolusic E; Frédérick R; De Plaen E; Uyttenhove C; Wouters J; Masereel B; Van den Eynde BJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2497-502. PubMed ID: 22308364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heme-containing enzymes and inhibitors for tryptophan metabolism.
    Yan D; Lin YW; Tan X
    Metallomics; 2017 Sep; 9(9):1230-1240. PubMed ID: 28650043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the IDO1 pathway in cancer: from bench to bedside.
    Liu M; Wang X; Wang L; Ma X; Gong Z; Zhang S; Li Y
    J Hematol Oncol; 2018 Aug; 11(1):100. PubMed ID: 30068361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and biological evaluation of a new type of dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase from ethnomedicinal plant Dactylicapnos scandens.
    Bao MF; Yang XN; Wu J; Liu JX; Cai XH
    Phytochemistry; 2023 Oct; 214():113794. PubMed ID: 37499850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers.
    Hoffmann D; Dvorakova T; Stroobant V; Bouzin C; Daumerie A; Solvay M; Klaessens S; Letellier MC; Renauld JC; van Baren N; Lelotte J; Marbaix E; Van den Eynde BJ
    Cancer Immunol Res; 2020 Jan; 8(1):19-31. PubMed ID: 31806639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of paeoniflorin from Paeonia lactiflora pall. As an inhibitor of tryptophan 2,3-dioxygenase and assessment of its pharmacological effects on depressive mice.
    Liang X; Su T; Wu P; Dai Y; Chen Y; Wang Q; Cao C; Chen F; Wang Q; Wang S
    J Ethnopharmacol; 2023 Dec; 317():116714. PubMed ID: 37315645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.